Article Text

Download PDFPDF

19 Myocardial perfusion mapping in cardiac amyloidosis- unearthing the spectrum from infiltration to ischaemia
  1. Tushar Kotecha1,
  2. Ana Martinez-Naharro1,
  3. James Brown1,
  4. Callum Little1,
  5. Daniel Knight1,
  6. Alexandros Steriotis1,
  7. Niket Patel1,
  8. Roby Rakhit1,
  9. Philip Hawkins1,
  10. Julian Gillmore1,
  11. James Moon2,
  12. Hui Xue3,
  13. Peter Kellman3,
  14. Marianna Fontana1
  1. 1National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, UK
  2. 2Barts Heart Centre, West Smithfield, London, UK
  3. 3National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA


Background Cardiac involvement is the main driver of outcome in systemic amyloidosis, but the relationship between amyloid deposits and outcomes is not well understood. The simple explanation of physical, mechanical replacement of the interstitium by amyloid seems insufficient. Preliminary studies support the hypothesis that myocardial ischaemia could contribute to cell damage.

Purpose (1) To assess myocardial ischaemia in cardiac amyloidosis. (2) To compare patients with cardiac amyloidosis to patients assessed on invasive coronary angiography (ICA) to have normal coronary physiology (NCP), microvascular dysfunction (MVD) and triple vessel coronary disease (3VD). (3) To assess correlation of perfusion mapping to markers of disease severity and prognosis.

Methods 86 patients and 20 healthy volunteers (HV) underwent CMR at 1.5T (Siemens) with standard cine, PSIR-LGE, T1,T2,Extracellular Volume (ECV) mapping and adenosine stress with myocardial blood flow (MBF) mapping. Thirty-eight patients also underwent ICA with 3 vessel assessment of Index of Microcirculatory Resistance and Fractional Flow Reserve: 7 had cardiac amyloidosis, 8 had NCP, 15 had MVD and 8 had 3VD.

Results Cardiac amyloidosis patients had severe reduction in stress MBF and myocardial perfusion reserve (MPR) (1.22 ml/g/min±0.70 and 1.62±0.63) compared to HV (3.21 ml/g/min±0.64,p<0.001 and 4.17±0.78, p<0.001), NCP (2.66±0.56, p<0.001 and 2.51±0.43, p=0.036) and MVD (2.10±0.31, p<0.001 and 2.29±0.87, p=0.014) with the degree of reduction being similar only to patients with 3VD (1.44±0.54,p=1.000 and 1.64±0.68,p=1.000) (figure 1). Rest MBF was also lower in amyloidosis than HV. Cardiac amyloidosis stress MBF and MPR inversely correlated with amyloid burden (ECV, r=−0.715, p<0.001, transmurality of LGE, p<0.01), systolic dysfunction (EF, r=0.405, p<0.01), and blood biomarkers (NT-proBNP (r=−0.678, p<0.001) and Troponin T (r=−0.628, p<0.001)). There was a correlation between stress MBF and native T1 (r=−0.588, p<0.001) but not T2 (p=0.591). Stress MBF and MPR were early disease markers, being elevated in patients with early cardiac amyloid infiltration (raised ECV, no LGE, p<0.01 vsHV).

Abstract 19 Figure 1

Short axis cine SSFP images ¡n end-diastole, corresponding native T1 mapping, late gadolinium enhancement (LGE) images, ECV Mapping and stress myocardial blood flow mapping in a normal subject, a patient with early cardiac infiltration (raised ECV, no LGE), a patient with cardiac amyloidosis, a patient with severe three vessel coronary disease

Conclusion Myocardial ischaemia is common in cardiac amyloidosis – with stress MBF and MPR similar to that of patients with 3VD. The reduction correlates with the degree of amyloid infiltration and markers of adverse prognosis, highlighting the potential role of myocardial ischaemia as a key mechanism in the pathophysiology of cardiac amyloidosis.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.